University of Minnesota. Driven to Discover.
The paper reflects current, evolving data, an expert says.
At least 20% of all primary care antibiotics could be classified as inappropriate.
The AMR Industry Alliance says more commitment and funding are needed.
Researchers identify more than 80 genes that contribute to resistance.
Four research teams from India receive awards for point-of-care diagnostic tests, 3 of them focused on sepsis.
A review finds the biomarker cut mortality and antibiotic exposure in patients with acute respiratory infections.
Recommendations focus on public-private R&D funding, incentives, and other steps.
The fast, automated assay performs well against gold standard TB tests.
Point-of-care tests, shared decision making, and procalcitonin-guided therapy were singled out.
Funds will help combat resistance, launch a TB surveillance center.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.